Impact of tucatinib on progression free survival in patients with HER2+metastatic breast cancer and stable or active brain metastases

被引:5
作者
Bachelot, T. [1 ]
Lin, N. U. [2 ]
Murthy, R. K. [3 ]
Hurvitz, S. A. [4 ]
Borges, V. [5 ]
Oliveira, M. [6 ]
Oakman, C. [7 ]
Khan, S. [8 ]
Lynch, C. [9 ]
Westbrook, K. [10 ]
Doyle, C. [11 ]
Reinisch, M. [12 ]
Colleoni, M. A. [13 ]
Slamon, D. [4 ]
Hortobagyi, G. N. [3 ]
Winer, E. P. [2 ]
McGoldrick, S. [14 ]
An, X. [15 ]
Loibl, S. [16 ]
机构
[1] Ctr Leon Berard, Med Oncol, Lyon, France
[2] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Breast Med Oncol, Houston, TX 77030 USA
[4] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Med Ctr, Med Oncol, Los Angeles, CA 90095 USA
[5] Univ Colorado, Ctr Canc, Med Med Oncol, Aurora, CO USA
[6] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Med Oncol, Barcelona, Spain
[7] Sunshine Hosp, Dept Oncol, St Albans, Vic, Australia
[8] Nottingham Univ Hosp NHS Trust, Med Oncol, Nottingham, England
[9] Canc Treatment Ctr Amer Phoenix, Med Oncol, Goodyear, AZ USA
[10] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[11] Univ Laval, Hop St Sacrement, CHU Quebec, Hematol Oncol, Quebec City, PQ, Canada
[12] Kliniken Essen Mitte Evang Huyssens Stiftung, Breast Unit, North Rhine Westphalia, Germany
[13] Ist Europeo Oncol, Med Oncol, Milan, Italy
[14] Seattle Genet Inc, Clin Dev, Seattle, WA USA
[15] Seattle Genet Inc, Biostat, Bothell, WA USA
[16] German Breast Grp GBG Forsch GmbH, Dept Med & Res, Neu Isenburg, Germany
关键词
D O I
10.1016/j.annonc.2020.08.395
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
293P
引用
收藏
页码:S359 / S360
页数:2
相关论文
empty
未找到相关数据